Welcome to our dedicated page for Hsbc Holdings Plc SEC filings (Ticker: HSBC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The HSBC Holdings plc (HSBC) SEC filings page provides access to the company’s regulatory disclosures as a foreign private issuer. HSBC files annual reports on Form 20‑F and frequent current reports on Form 6‑K, which together give investors detailed information about its global banking and financial services operations, capital structure, governance, and risk profile.
Form 6‑K filings for HSBC include a variety of disclosures, such as dividend announcements, voting rights and capital updates, board and senior management changes, and information on regulatory matters like Bank of England bank capital stress test results. Other 6‑K submissions cover employee share and incentive plans, including block listing six‑monthly returns and grants of conditional awards under the HSBC International Employee Share Purchase Plan and other share plans.
Filings also document transactions by persons discharging managerial responsibilities (PDMRs), where HSBC reports acquisitions of ordinary shares through dividend reinvestment or other mechanisms, in line with market abuse regulations. In addition, HSBC uses SEC filings to communicate significant group developments, such as joint announcements related to the proposed privatization of Hang Seng Bank Limited and associated listing withdrawal processes.
On Stock Titan, these filings are updated in near real time from the SEC’s EDGAR system. AI‑powered summaries help explain the content of lengthy documents, highlighting key points from annual reports (Form 20‑F), interim updates, dividend declarations, capital and voting rights notices, and share plan disclosures. Investors can quickly see what has changed, how board and governance announcements may affect oversight, and how share‑based compensation plans impact potential dilution.
Users interested in insider‑related activity can review PDMR transaction notices, while those focused on earnings, capital, and risk can turn to dividend and stress test‑related filings. Together, these documents form an official record of HSBC’s regulatory communications, supporting deeper analysis of HSBC stock.
HSBC Holdings plc cancelled 26,782,800 ordinary shares of US$0.50 each on 6 November 2025. These shares had been repurchased on the Hong Kong Stock Exchange under the buy-back announced on 31 July 2025.
After this cancellation, HSBC has 17,175,239,862 ordinary shares in issue, with no shares held in treasury. The total number of voting rights is 17,175,239,862, which shareholders may use as the denominator for disclosure calculations under applicable UK and Hong Kong rules.
HSBC Holdings plc reported the grant of conditional awards to employees and former employees to subscribe for a total of 501,618 ordinary shares of US$0.50 each under the HSBC Share Plan 2011. The purchase price of the awards is GBP 0, and the closing market price on the London Stock Exchange on the grant date was GBP 10.75.
Under the group-wide deferral policy, vesting occurs over three years with 33% on the first and second anniversaries and 34% on the third; certain Material Risk Takers may have vesting up to seven years. Awards may carry a six- or 12‑month retention period. Some awards are tied to completion of a strategically important project; clawback applies in line with internal policy and buy-out award terms. Shares available for future issue under plan limits are 989,931,663 (10% limit) and 275,655,010 (5% limit).
HSBC Holdings plc reported a management dealing: on 4 November 2025, Ian Stuart, Chief Executive of HSBC UK Bank plc, exercised options to purchase 11,419 ordinary shares of US$0.50 each under the HSBC Holdings Savings-Related Share Option Plan at an option price of £2.627 per share.
The transaction was recorded on the London Stock Exchange Main Market. The filing’s transaction table shows a total of £29,997.71 for the exercise.
The New York Stock Exchange LLC filed a Form 25 to remove from listing and/or registration, under Section 12(b) of the Exchange Act, HSBC Holdings plc 7.336% Fixed Rate/Floating Rate Senior Unsecured Notes due 2026.
The notice references compliance with Exchange rules to strike the class from listing and includes statements regarding issuer compliance with voluntary withdrawal requirements.
HSBC Holdings plc launched three senior unsecured note offerings: $2,250,000,000 4.619% fixed-to-floating notes due 2031, $2,250,000,000 5.133% fixed-to-floating notes due 2036, and $500,000,000 floating-rate notes due 2031. The 2031 series pay 4.619% until November 6, 2030, then a SOFR-based floating rate plus 1.190% to maturity on November 6, 2031. The 2036 series pay 5.133% until November 6, 2035, then a SOFR-based floating rate plus 1.430% to maturity on November 6, 2036. The $500,000,000 tranche pays a SOFR-based floating rate plus 1.190% to November 6, 2031.
Redemption terms include make-whole for the fixed/floating tranches and par calls on November 6, 2030 (2031 notes) and November 6, 2035 (2036 notes); the floating-rate notes are callable at par on November 6, 2030. Expected NYSE listing is within 30 days of initial delivery. Stated proceeds before expenses are $2,243,250,000, $2,241,000,000, and $498,500,000, with underwriting discounts shown as 0.300%, 0.400%, and 0.300%, respectively. Key risks include agreement to UK bail-in powers and limited remedies with no acceleration for non-payment except upon certain winding-up events.
HSBC Holdings plc updated its share capital and voting rights. As of 30 October 2025, the company had 17,201,971,220 ordinary shares of US$0.50 in issue, with no shares held in treasury.
This means the total number of voting rights is 17,201,971,220. Shareholders can use this figure as the denominator when assessing whether their holdings trigger disclosure requirements under UK and Hong Kong rules.
HSBC Holdings plc reported a manager share transaction. On 29 October 2025, Group Chief Information Officer Stuart Riley sold 22,404 ordinary shares of US$0.50 each at £10.69 per share on the London Stock Exchange, for a total of £239,498.76. The disclosure is made in accordance with the UK version of the EU Market Abuse Regulation.
HSBC Holdings filed a joint update on the proposal to privatise Hang Seng Bank via a scheme of arrangement under section 673 of the Companies Ordinance. With the Executive’s consent under Rule 8.2 of the Takeovers Code, the latest date to despatch the Scheme Document has been extended from 30 October 2025 to 17 December 2025.
A detailed timetable will be set out in the Scheme Document and a joint announcement upon despatch. On the basis that despatch occurs on or before 17 December 2025, and subject to the satisfaction (or, if applicable, waiver) of the Conditions, the proposal is currently expected to complete within the first quarter of 2026.
The update reiterates the standard caution that the proposal will only proceed if all Conditions are met or waived by the Conditions Long Stop Date, and advises care when dealing in the securities of HSBC Holdings and Hang Seng Bank.
HSBC Holdings plc announced the publication of a Base Prospectus Supplement dated 29 October 2025 to its 28 March 2025 Base Prospectus (with prior supplements dated 30 April 2025 and 31 July 2025). The supplement has been approved by the Financial Conduct Authority and is now available via HSBC’s issuance programmes page and will be submitted to the FCA’s National Storage Mechanism.
The notice reiterates distribution restrictions: any notes under the programme may be offered outside the United States to non‑U.S. persons under Regulation S, or within the United States to Qualified Institutional Buyers in accordance with Rule 144A. HSBC reports assets of US$3,234bn as of 30 September 2025.
HSBC Holdings plc reported a PDMR share transaction on a Form 6-K. On 27 October 2025, Ian Stuart, Chief Executive of HSBC UK Bank plc, acquired 16 ordinary shares under the UK Share Incentive Plan at £9.94564 per share. The total consideration was £159.13. The shares have a nominal value of US$0.50 and the transaction took place on the London Stock Exchange (XLON).